Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.8 CHF | -1.55% |
|
-0.85% | +37.13% |
06-18 | Switzerland's Cosmo Pharmaceuticals Receives Drug Registration Certificate for Lumeblue in China | MT |
06-03 | Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.13% | 1.27B | |
+54.50% | 815B | |
+44.25% | 654B | |
-6.15% | 354B | |
+20.84% | 337B | |
+11.09% | 302B | |
+18.45% | 247B | |
+2.09% | 229B | |
+13.03% | 219B | |
+8.26% | 171B |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Switzerland's Cosmo Pharmaceuticals Receives Drug Registration Certificate for Lumeblue in China